Internet-based profiler system as integrative framework to support translational research

BMC Bioinformatics

Volumn 6, Issue , 2005, Pages

  Kim, Robert ^a   Demichelis, Francesca ^a,b   Tang, Jeffery ^a   Riva, Alberto ^c   Shen, Ronglai ^d   Gibbs, Doug F ^e   Mahavishno, Vasudeva ^e   Chinnaiyan, Arul M ^d,e   Rubin, Mark A ^a,b,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC INSTITUTIONS; DIAGNOSIS AND PROGNOSIS; HEMATOPOIETIC SYSTEMS; INTEGRATIVE FRAMEWORK; MOLECULAR BIOMARKER; RELATIONAL DATABASE; TISSUE MICROARRAYS; TRANSLATIONAL RESEARCH;

DIAGNOSIS; EXPERIMENTS; INTERNET; TISSUE; TISSUE ENGINEERING;

DISTRIBUTED DATABASE SYSTEMS;

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; AUTOMATION; COMPUTER AIDED DESIGN; COMPUTER ANALYSIS; DATA ANALYSIS; DISEASE MARKER; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC DATABASE; HUMAN; HUMAN COMPUTER INTERACTION; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; INTERNET; MEDICAL RESEARCH; PROFESSIONAL SECRECY; PROTEIN EXPRESSION; RELIABILITY; TISSUE MICROARRAY; TISSUE SECTION; BIOLOGY; COMPUTER LANGUAGE; COMPUTER PROGRAM; DATA BASE; DNA MICROARRAY; GENE EXPRESSION PROFILING; METABOLISM; NEOPLASM; PROCEDURES;

AUTOMATION; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DATABASE MANAGEMENT SYSTEMS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERNET; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGRAMMING LANGUAGES; SOFTWARE; SOFTWARE DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 29944441992     PISSN: 14712105     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-6-304     Document Type: Article

References (47)

1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4(7):844-847.
2. Mucci NR, Akdas G, Manely S, Rubin MA: Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 2000, 31(4):406-414.
3. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U et al: Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001, 194(3):349-357.
4. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML: E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 2001, 32(7):690-697.
5. Rubin MA, Dunn R, Strawderman M, Pienta KJ: Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002, 26(3):312-319.
6. Bova GS, Parmigiani G, Epstein JI, Wheeler T, Mucci NR, Rubin MA: Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. Hum Pathol 2001, 32(4):417-427.
7. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002, 8(11):1323-1327.
8. Chen W, Foran DJ, Reiss M: Unsupervised imaging, registration and archiving of tissue microarrays. Proc AMIA Symp 2002:136-139.
9. Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M: Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002, 161(5):1557-1565.
10. Manley S, Mucci NR, De Marzo AM, Rubin MA: Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. Am J Pathol 2001, 159(3):837-843.
11. Berman JJ, Datta M, Kajdacsy-Balla A, Melamed J, Orenstein J, Dobbin K, Patel A, Dhir R, Becich MJ: The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource. BMC Bioinformatics 2004, 5(1):19.
12. Liu X, Minin V, Huang Y, Seligson DB, Horvath S: Statistical methods for analyzing tissue microarray data. J Biopharm Stat 2004, 14(3):671-685.
13. Chaib H, Rubin MA, Mucci NR, Li L, Taylor JMG, Day ML, Rhim JS, Macoska JA: Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res 2001, 61(6):2390-2394.
14. De Marzo AM, Fedor HH, Gage WR, Rubin MA: Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays. Hum Pathol 2002, 33(7):756-760.
15. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412(6849):822-826.
16. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF et al: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003, 100(20):11606-11611.
17. Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR et al: alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 2002, 161(3):841-848.
18. Perrone EE, Theoharis C, Mucci NR, Hayasaka S, Taylor JM, Cooney KA, Rubin MA: Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. J Natl Cancer Inst 2000, 92(11):937-939.
19. Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA: Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 2003, 95(9):661-668.
20. Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA: Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 2001, 158(5):1767-1773.
21. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA: Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003, 162(1):255-261.
22. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA: Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002, 26(7):926-931.
23. Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS: Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 2002, 110(3):351-360.
24. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS: Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003, 89(3):462-473.
25. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM: alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Jama 2002, 287(13):1662-1670.
26. Rubin MA, Zerkowski MP, Camp RL, Kuefer R, Hofer MD, Chinnaiyan AM, Rimm DL: Quantitative Determination of Expression of the Prostate Cancer Protein alpha-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA): A Novel Paradigm for Automated and Continuous Biomarker Measurements. Am J Pathol 2004, 164(3):831-840.
27. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, Shapiro GI, Gschwend JE, Hautmann RE, Sanda MG, Giehl K et al: The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 2004, 64(3):825-829.
28. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, Macvicar GR, Varambally S, Harwood J, Bismar TA et al: Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 2004, 64(24):9209-9216.
29. Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA et al: Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res 2004, 64(11):3814-3822.
30. Jagged: http://rubinlab.tch.harvard.edu/supplemental_data/JAGGED1/ index.jsp.
31. Profiler: http://Profiler.tch.harvard.edu.
32. Shaknovich R, Celestine A, Yang L, Cattoretti G: Novel relational database for tissue microarray analysis. Arch Pathol Lab Med 2003, 127(4):492-494.
33. TMAJ: http://tmaj.pathology.jhmi.edu.
34. Bacus: http://www.bacuslabs.com/.
35. Aperio: http://www.aperio.com.
36. Pathfinder: http://www.imstar.fr/.
37. Demichelis F, Sboner A, Barbareschi M, Dell'Anna R: TMABoost: an integrated system for comprehensive management of Tissue Microarray data. IEEE - Transactions on Information Technology in Biomedicine In Press.
38. Dell'Anna R, Demichelis F, Barbareschi M, Sboner A: An automated procedure to properly handle digital images in large scale Tissue Microarray experiments. Computer Methods and Programs in Biomedicine In Press.
39. Berman JJ, Edgerton ME, Friedman BA: The Tissue Microarray Data Exchange Specification: A community-based, open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak 2003, 3(1):5.
40. NBNPILOT: http://prostatenbnpilot.nci.nih.gov/.
41. Grid CBI: http://cabig.nci.nih.gov/caBIG/.
42. APache: http://httpd.apache.org.
43. Tomcat: http://jakarta.apache.org/tomcat/index.html.
44. MySQL: http://www.mysql.com/.
45. PostgresSQL: http://www.postgresql.org/.
46. Resource CPCT: http://www.prostatetissues.org/. In.
47. HIPPA: http://www.hhs.gov/ocr/hipaa/.